DERM Long Call Strategy

DERM (Journey Medical Corporation), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.

Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.

DERM (Journey Medical Corporation) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $177.0M, a beta of 1.08 versus the broader market, a 52-week range of 4.31-9.555, average daily share volume of 246K, a public-listing history dating back to 2021, approximately 58 full-time employees. These structural characteristics shape how DERM stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.08 places DERM roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a long call on DERM?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

DERM snapshot

As of August 14, 2026, spot at $6.68, ATM IV 288.00%, IV rank 61.97%, expected move 82.57%. The long call on DERM below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this long call structure on DERM specifically: DERM IV at 288.00% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 82.57% (roughly $5.52 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DERM expiries trade a higher absolute premium for lower per-day decay. Position sizing on DERM should anchor to the underlying notional of $6.68 per share and to the trader's directional view on DERM stock.

DERM long call setup

The DERM long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DERM at $6.68 on that close, the first option leg uses a $6.68 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DERM chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DERM shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$6.68N/A

DERM long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

DERM long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on DERM. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on DERM

Long calls on DERM express a bullish thesis with defined risk; traders use them ahead of DERM catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

DERM thesis for this long call

The market-implied 1-standard-deviation range for DERM extends from approximately $1.16 on the downside to $12.20 on the upside. A DERM long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current DERM IV rank near 61.97% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on DERM should anchor more to the directional view and the expected-move geometry. As a Healthcare name, DERM options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DERM-specific events.

DERM long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DERM positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DERM alongside the broader basket even when DERM-specific fundamentals are unchanged. Long-premium structures like a long call on DERM are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current DERM chain quotes before placing a trade.

Frequently asked questions

What is a long call on DERM?
A long call on DERM is the long call strategy applied to DERM (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With DERM stock at $6.68 on the most recent close, the strikes shown on this page are snapped to the nearest listed DERM chain strike and the premiums come straight from that session's bid/ask midpoint.
How are DERM long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the DERM long call priced from the end-of-day chain at a 30-day expiry (ATM IV 288.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a DERM long call?
The breakeven for the DERM long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The DERM market-implied 1-standard-deviation expected move in the same options snapshot is approximately 82.57%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on DERM?
Long calls on DERM express a bullish thesis with defined risk; traders use them ahead of DERM catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current DERM implied volatility affect this long call?
DERM ATM IV is at 288.00% with IV rank near 61.97%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related DERM analysis